Opentrons addresses the costly, complex, and manual nature of laboratory work with open, modular robots and AI-enabled software; it has deployed more than 11,000 robots to laboratories in over 80 countries, including 90% of the top 20 global pharmaceutical companies. The $40M Series E led by Avego and joined by BroadOak is intended to scale the robotics, software, and data infrastructure that the company says can become the execution layer for autonomous science.